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Abstract 
Fenugreek (Trigonella foenum-graecum L.) is a medicinal plant used worldwide since ancient times. Its use as smelling agent 
and spice was documented since 15th century. The genus Trigonella includes around 260 species diffused worldwide and 
belonging to Fabaceae family. In the last decades, a number of studies highlighted the biological activities and therapeutic 
properties of this species mainly attributed to bioactive secondary metabolites such as alkaloids, flavonoids, steroids and 
saponins. In particular, diosgenin, a steroidal saponin, has been investigated for its medicinal uses and fenugreek has been 
reported as source of raw material for the production of steroidal hormones. This review article focuses on the cultivation, 
genetics, ecophysiology and traditional uses of fenugreek, as well as on its medicinal properties, phytochemical and nutrient 
contents. Extraction procedures and pharmacological activities of diosgenin are also reviewed, as well as methods for its 
chemical analyses. This review focuses on the medicinal importance of Fenugreek and its important secondary metabolite 
diosgenin. The review article complies the results of pre-clinical studies conducted to establish the various medicinal 
applications of diosgenin. This will help researcher to discover fundamental role of diosgenin as a potential product for drug 
manufacturers and use of fenugreek as a source of diosgenin. 
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Introduction 
Trigonella foenum-graecum L. (fenugreek) is widely used 
for its medicinal properties all over the world and it is a very 
important spice in Indian culture. Around 260 species of 
Trigonella are diffused worldwide (Acharya, 2006). The 
genus name Trigonella means ‘tri-angled’, maybe because of 
triangular shape of its flowers, whereas the species name 
foenum-graecum means ‘Greek hay’ (Petropoulos, 2002). It 
is an annual crop and dicotyledonous plant belonging to the 
subfamily Papilionaceae, family Fabaceae. The plant is erect 
or branched and, generally, grows to a height of about 30-60 
cm, depending on the variety. It has trifoliate, pinnate 
leaves; roots bearing nodules; white to yellow flowers, 
flowering 30-40 days after sowing; 3-15 cm long, thin 
pointed, hoop-like pods; golden yellow seeds (Petropoulos, 
2006; Basch et al., 2003; Acharya, 2008; Moradi and 
Moradi, 2013). 
It is believed that fenugreek was native from Europe, 
though De Candolle mentioned that it could be a plant 
from Indian origin. If fenugreek was from European origin, 
then, it should be common in Europe, but this is not the 
case. Fazli and Hardman reported that fenugreek was native 
from Punjab and Kashmir, Mesopotamia desert, Persia and 
some European countries as Greece, Italy and Spain 
(Linnaeus, 1753; De Candolle, 1886; Fazli and Hardman, 
1968). The fenugreek leaves were used to produce the 
Egyptian incense Kuphi, a holy smoke used in fumigation 
and embalming rites (Rosengarten, 1969). Well 
documented fenugreek uses date back to 15th century. 
Melius compiled the details of this plant species in the well-
known Kolozsvar Herbarium, in 1578 (Petropoulos, 2003). 
Hidvegi mentioned some uses of fenugreek, in 16th century 
(Hidvegi, 1984). Howard reported that the fenugreek seed 
powder was used, in 17th century, to expel placenta after 
child birth (Howard, 1987). Despite its uses since centuries, 
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Diverse fenugreek genotypes are present in the world, 
differing in growth habits, morphology, seed quality and 
crop yield. Since fenugreek is a self-pollinating plant, 
breeders successfully developed varieties by using breeding 
techniques. Some of the most important fenugreek varieties 
diffused throughout the world are summarized in Table 1. 
Nowadays, fenugreek is used in various countries: as 
spice in Iran, for preparing flavor cheese in Switzerland, seed 
powder along with flour for making flat bread in Egypt, 
seedlings as vegetable in India and Pakistan (Moradi and 
Moradi, 2013). In Africa, people use fenugreek seeds as 
coffee-substitute, to control insect infestations in grain 
storages, in cosmetic industries and so on. 
 
Fenugreek genetics 
The few data available on fenugreek kariotype and 
genome have identified the somatic chromosome numbers 
of Trigonella taxa as 2n = 14, 16, 30 and 46 along with B 
chromosomes (Martin et al., 2011; Vaidya et al., 2013). The 
C-value of fenugreek was found to be 0.7, which is 1.5 fold 
higher than the values of model legumes Lotus corniculatus 
L. var. japonicus Regel [syn. Lotus japonicus (Regel) K. 
Larsen] and barrel (Medicago truncatula Gaertn.); genome 
size of both these species is around 470Mbp, whereas the 
genome size of fenugreek is around 685Mbp (Young et al.,
2003; Vaidya et al., 2013). Despite fenugreek is an 
important medicinal plant, its whole genome sequencing 
has not been carried out yet, and only transcriptome 
sequencing data were published earlier by our research 
group. The transcriptome contains 42 million high quality 
reads, with 18,333 transcripts functionally annoted and 
6,775 transcripts related to metabolic pathways including 
diosgenin biosynthesis (Vaidya et al., 2013). In particular, 
targeting transcriptome sequencing of fenugreek has been 
fenugreek was not studied in detail in the past, even if, since 
the last decades, its biological activities are seeking attention 
of the scientific community. 
This review article focuses on the genetics of fenugreek, 
as well as on its medicinal properties, phytochemical and 
nutrient contents. Extraction procedures and pharmaco-
logical activities of diosgenin are also reviewed, as well as 
methods for its chemical analyses. 
Fenugreek Plant 
Fenugreek cultivation, varieties and uses in the world 
Fenugreek has good adaptability to diverse atmospheric 
conditions, temperatures and soils which makes it cultivable 
in different habitats and more than 20 countries of Asia, 
Europe, Africa, America and in some areas of Australia (Fig. 
1), where it is used as food ingredient, flavoring agent, herb 
and spice (Rouk and Mangesha, 1963; Fazli and Hardman, 
1968; Rosengarten, 1969). In India, fenugreek is cultivated 
mainly in Rajasthan (around 80% of the national 
production), Gujarat, Uttaranchal, Uttar Pradesh, Madhya 
Pradesh, Maharashtra, Haryana and Punjab. 
23
Fig. 1. Cultivation of Trigonella foenum-graecum L. in the 
world; in green, countries were fenugreek is cultivated 
 
Table 1. List of fenugreek varieties available worldwide 
Fenugreek Variety Country References 
CO-1, Rajendra Kanti, RMt-1, LamSel 1, Pusa Early Bunching India Edison (1995) 
UM-9, UM-17, UM-18, UM-23, UM-25, UM-26, UM-27, UM-32, UM-33, UM-36, UM-50, UM-52, UM-58, 
UM-67, UM-70, UM-75, UM-77, UM-79, UM-83, UM-84, M-105, UM-112, UM-113, UM-114, UM-115, CVT 
UM-5, CVT UM-17, CVT UM-32, CVT UM-34, CVT UM-35, CVT UM TC 2336, CVT TG 1084, CVT GF 
1, CVT CC, CVT NLM, NLM, CO 1, Local check, CT Lam Sel 1 
India Kamal et al. (1987) 
RG-07, TG-3, TG-13, TG-18, TG-24, TG-34, UM-5, UM-6, UM-17, UM-20, UM-34, UM-35, UM-38, NI-01, 
MP-14, IC-99, LamSel 1, Local Bobes, Pusa Earlier, Bangalore-Local 
India Prasad and Hiremath (1985) 
T-8 India Paroda and Karwasra (1975) 
HM-46 India Singh et al. (1994) 
IC-74 India Singh and Singh (1974) 
‘Gharbin-6’ Egypt Bunting (1972) 
‘Ali Lunghe’, ‘Ali Corte’ Italy Del’ Gaudio (1953) 
Ionia Greece Vaitsis (1985); Anonymous (1996) 
Gouta France Haefele et al. (1997) 
Fluorescent, Ethiopian England Petropoulos (1973) 
Barbara, Margaret, Paul England Hardman (1980); Evans (1991) 
Fluorescent, Ethiopian, Kenyan, Moroccan England Petropoulos (1973) 
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24 
studied by Vaidya et al. in order to identify the genes of 
diosgenin pathway (Vaidya et al., 2013). Studies on 
fenugreek genome should be improved, since they could 
provide information about the bioactive phytochemicals of 
this important medicinal plant. 
 
Ecophysiology of fenugreek plants 
As previously introduced, fenugreek is widely 
distributed in most parts of the world because of its 
adaptation to different climatic conditions and 
environments (Fig. 1). This plant is tolerant to drought and 
able to grow well in areas with moderate to low rainfall; its 
temperature requirement is as low as 10-15 °C, though it 
can neither grow well in extreme high nor in extreme low 
temperatures (Talelis, 1967; Duke, 1986). For instance, in 
Greece, fenugreek is cultivated both in summer and winter, 
because of its adaptive nature (Talelis, 1967). It has been 
reported that the maximum fenugreek yield occurs in areas 
where dry season with low temperatures follows rainy 
season, which are the typical subtropical and Mediterranean 
conditions. Ethiopian fenugreek is cultivated in areas having 
climatic conditions similar to the Mediterranean region 
ones (Rouk and Mangesha, 1963). In India and Egypt, 
fenugreek is grown in winter (Pareek and Gupta, 1981), 
though in Germany it is cultivated at the beginning of 
spring. For Indian weather, early sowing around the middle 
of October gave higher yields than late sowing around the 
middle of November (Rathore and Manohar, 1989). Crop 
improvement can play significant role in increasing yield for 
any plant. Many studies demonstrated work for fenugreek 
crop improvement (Petropoulos, 2002; Acharya et al.,
2008). Different crop improvement techniques are popular 
from which majorly used methods are: consequent selection 
from all available accessions, artificial crossing and 
mutational breeding. In case of fenugreek, artificial crossing 
is difficult because it is self-pollinated plant. Mutational 
breeding and consequent selection among world accessions 
are better ways to improve the crop (Petropoulos, 2002), 
and much of the breeding with fenugreek has utilized these 
two approaches. 
 
Fenugreek phytochemicals and nutrients 
The three main classes of fenugreek secondary 
metabolites include saponins, flavonoids and alkaloids. This 
plant seeds were reported to contain 35% alkaloids, 10% 
flavonoids (100 mg per g of fenugreek seeds), 4.8% saponins 
and 0.2-0.9% diosgenin (Jani, 2009; Meghwal, 2012; 
Vaidya, 2013). Alkaloids, along with some other volatile 
compounds, are mainly responsible for the bitter taste and 
typical aroma of fenugreek (Kumar, 2012, Faeste, 2009). 
Additionally, it is a significant source of vitamin B1, iron, 
silicon, sodium, protein, amino acids, fatty acids and dietary 
fiber (Sharma et al., 1990). In particular, the plant is rich in 
soluble fiber, mucilage and galactomannan which decrease 
the uptake of bile salts and starch absorption (Madar, 1990). 
Fenugreek seeds contain the amino acid 4-
hydroxyisoleucine which increases insulin secretion 
(Haefelé et al., 1997). The plant also represents a significant 
source of antioxidants (Naidu, 2011). In obese subjects, 
short-term beneficial effects of fenugreek fiber were 
reported on satiety, blood glucose, insulin response and 
energy intake (Mathern et al., 2009). In addition, fenugreek 
fiber can bind to and remove carcinogens in the intestine 
(Meghwal, 2012). 
 
Fenugreek traditional uses 
As previously introduced, fenugreek use as herbal 
remedy in traditional healing systems dates back to 15th
century. Dried seeds and leaves, in different forms, were 
used for curing many symptoms and ailments. For instance, 
a paste prepared with ground fenugreek seeds was used to 
treat eczema, rash or inflammatory conditions. 
Ethnoveterinary uses of fenugreek were also documented. 
Traditional uses of fenugreek are summarized in Table 2. 
 
Therapeutic properties 
A number of pharmacological activities have been 
investigated in order to clarify the therapeutic properties of 
fenugreek and its main metabolites (Mehrafarin et al.,
2010). Some studies have been carried out on extracts from 
different plant parts (seeds, leaves) or pure phytochemicals 
(saponins, steroids, alkaloids) to validate traditional uses of 
fenugreek as herbal remedy. These studies, reported in 
Table 3, investigate, in some cases, the pharmacological 
mechanisms by different experimental models. 
 
Need of improvement in fenugreek cultivation 
In India, fenugreek was grown in 94,760 and 93,605 
hectares, in the years 2010-2011 and 2011-2012, 
respectively, with a production of 12,785 and 11,529 
million tons, respectively. The production of fenugreek was 
1.34 and 1.23 million tons per hectare, in the years 2010-
2011 and 2011-2012, respectively (Vidyashankar, 2014). In 
India, eight research and development projects were 
planned for spices including fenugreek along with research 
institutions and state universities under the All India 
Coordinated Research Project13. However, researchers 
found difficulties in growing fenugreek due to the lack of 
information regarding this plant (Petropoulos, 2002). 
Therefore, varieties and techniques to improve fenugreek 
quality and yield from poor lands are urgently needed in 
such scenario. 
Diosgenin 
As previously reported, fenugreek is a rich source of 
saponins such as yamogenin, tigogenin and diosgenin. 
Diosgenin is the most important out of all four mentioned 
secondary metabolites. It has a molecular weight of 414.621 
g mol-1 and is made up of 27 carbon, 42 hydrogen and three 
oxygen atoms. Its scientific name is (3β,25R)-spirost-5-en-3-
ol, C27H42O3 and its chemical structure is illustrated in 
Fig. 2. It has estrogenic activity and represents the most 
important bioactive phytochemical in fenugreek, used as 
raw precursor for the industrial, large scale synthesis of 
steroidal drugs and hormones such as testosterone, 
norethisterone, glucocorticoids and progesterone. 
Diosgenin also exhibited anticancer and antiaging activities, 
as well as cardioprotective and contraceptive properties 
(Aradhna et al., 1992; Liu et al., 1993; Qin et al., 1997; Dias 
et al., 2007; Lee et al., 2007; Tada et al., 2009; Yan et al.,
2009; Gong et al., 2010; Agarwal et al., 2015). Russell 
Marker and colleagues developed the semisynthesis of 
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Table 2. Traditional uses of fenugreek 
Plant parts and preparation Symptoms or illnesses References 
Seeds Chapped lips, stomach irritation, mouth ulcers Duke (1986) 
Soaked seeds Constipation Fazli and Hardman (1968); Rosengarten (1969) 
Decoction 
(various parts) 
Tuberculosis, sore throat, infection of stomach and intestine, remedy for gonorrhea and 
vermin 
Schauenberg and Paris (1990); 
Fazli and Hardman (1968) 
Poultice of seeds 
Gouty pains, neuralgia, sciatica, swollen glands, wounds, furuncles, fistulas, tumours, sores, 
skin irritation, abscesses and carbuncles 
Sharma et al. (1996);  
Pandian et al. (2002) 
Crushed seeds with powdered charcoal Bruises, swellings, boils, ulcers, swelling of testicles 
Pandian et al. (2002); Bunney (1984);  
Reger (1993) 
Seeds Constipation and diarrhea Evans (1991); Sharma et al. (1996) 
Poultice of seeds (in Malaya) Burns, cough, dropsy, hepatomegaly, splenomegaly Duke (1986); Bhatti (1996); Sharma et al. (1996) 
Seeds (in China) 
Abdominal and hypogastric pain, chilblains, cholecystitis, fever, hernia, impotence, nephrosis 
and rheumatism 
Duke (1986) 
Fenugreek tea Soothing to the gastrointestinal tract Pandian et al. (2002) 
Alcoholic fenugreek extracts To expel poisons and unwanted materials from the human body Howard (1987) 
Seeds To prepare the base of medicinal preparation called ‘Luddoo’ Rouk and Mangesha (1963) 
Seed powder Inflammations and suppurations Fluck (1988) 
Seeds (aqueous extract) Antibacterial activity Bhatti et al. (1996) 
Decoction of the seeds Remedy for diabetes 
Evans (1991); Khosla et al. (1995);  
Sharma et al. (1996) 
Decoction of the seeds Substitute of insulin Oliver-Bever (1986) 
Seeds Anti-diabetic activity 
Daoud (1932); Valette et al. (1984);  
Oliver-Bever (1986); Evans (1991); 
Seeds To reduce serum cholesterol in animals Sharma et al. (1991) 
Seeds To increase milk production in animals Bunney (1984) 
Seeds Anticancer activity, fibromas Singhal et al. (1982); Evans (1991) 
Seeds To induce labour during child birth Yoshikawa et al. (1997) 
Various parts For treating weakness and oedema Basch et al. (2003) 
 
Table 3. Pharmacological activities of fenugreek 
Plant parts/ phytochemicals Pharmacological activities References 
Seed powder Decrease of glycaemia, improvement of symptoms in type-2 diabetes patients Mitra and Bhattacharya (2006) 
Seeds Decrease of glycaemia in type 2 diabetes patients 
Madar et al. (1988); Jain et al. 
(1995); Sharma et al. (1996) 
Seeds Diabetes control in type 1 diabetes patients Sharma et al. (1990) 
4-Hydroxyisoleucine extracted from seeds Increase of insulin secretion Sauvaire et al. (1998) 
Various parts Increased number of insulin receptors Raghuram et al. (1994) 
Various parts Increase of insulin secretion in animals Ethan et al. (2003) 
Alkaloids, flavonoids, saponins Decrease of lipaemia, glycaemia and cholagogic for treating diabetes mellitus Izzo et al. (2005) 
Extract rich in saponins Decrease of hypercholesterolemia in rats Petit et al. (1995) 
Seeds Management of long-term diabetes complications Ribes et al. (1986) 
Seeds Decrease of glycemia in diabetic patients 
Sowmya and Rajyalakhsmi 
(1999) 
Various parts Treatment of hyperglycemia in type-1 diabetic rats Basch et al. (2003) 
Aqueous extract (various parts) Ulcer protective Srinivasan (2006) 
Diet with 30% fenugreek seeds 
In female rabbits: antifertility and reduction of developing foetuses 
In male rabbits: decrease of testis weight, plasma concentration of androgens 
and sperm production 
Bin-Hafeez et al. (2003) 
Leaves and seeds Reduction of perspiration, fever, allergies, bronchitis and congestion Faeste et al. (2009) 
Seeds Treatment of sinus and lung congestion Singhal et al. (1982) 
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26 
Leaves and seeds Antimicrobial 
Sowmya and Rajyalakhsmi 
(1999) 
Leaves and seeds Treatment of hypertension and hypercholesterolemia 
Sowmya and Rajyalakhsmi 
(1999); Roberts (2012) 
Leaves and seeds Prevention of gas formation in digestive tract Mathern (2009) 
Steroids, flavonoids, alkaloids Raw material for hormones and pharmaceuticals Blank (1996) 
Leaves and seeds Antibacterial, anticancer, antiulcer, antinociceptive 
Sowmya (1999); Mathern 
(2009) 
 
Table 4. Pharmacological activities of diosgenin 
Pharmacological activities References 
Antifungal activity on Candida albicans, C. glabrata and C. tropicalis Sautor (2004) 
Inhibition of replication of hepatitis C virus (HCV) Wang (2011) 
Decrease of glycaemia and intestinal disaccharidases in vivo McAnuff (2006) 
Decrease of the activity of the ATP-citrate lyase, pyruvate kinase and glucose-6-phosphate dehydrogenase in the liver of 
diabetic rats 
McAnuff (2005) 
Inhibition of glucose-uptake and glucagon-induced hepatic glycogen phosphorylase A activity in vitro Al-habori (2001) 
Anticoagulant activity, inhibition of platelet aggregation and thrombosis in vivo Gong (2011) 
Decrease of plasma total cholesterol and LDL-cholesterol, increase of HDL-cholesterol and total cholesterol ratio in rats Xu et al. (2009) 
Enhancement of BK (Ca)-channel activity in human cortical neurons Wu (2006) 
Decrease of blood pressure, oxidative stress and cardiac remodeling in the heart of adenine-induced chronic renal failure rats Manivannan (2015) 
Increase of antioxidant level, decrease of ACE activity, lipid peroxidation level and cardiac fibrosis in chronic renal failure rats Manivannan (2015) 
Inhibition of platelet aggregation and acetylcholinesterase activity Sautour (2004) 
Decrease of serum total cholesterol levels in rats Ghayur (2011) 
Inhibition of accumulation of triglycerides and expression of lipogenic genes in mice Ma HY et al. (2002) 
In vivo increased levels of superoxide dismutase in the plasma and liver, glutathione peroxidase and catalases in erythrocytes Uemura (2011) 
Upregulation of antioxidant enzymes in rats Son et al. (2007) 
Suppression of inflammation within the atherosclerotic lesion in vivo Son et al. (2007) 
Anti-inflammatory activity in RAW 264 macrophages induced by the conditioned medium derived from 3T3-L1 adipocytes Choi et al. (2010) 
Food allergy, suppression of intestinal inflammation Hirai et al. (2010) 
G0/G1 arrest and inhibition of proliferation induced by IGF-1 in human thyroid cells Huang et al. (2009) 
Inhibition of migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinase expression Cai et al. (2014) 
Regulation of Jun N-terminal kinase, phosphatidylinositide-3 kinase/Akt signaling pathways and NF-κB activity in human 
prostate cancer PC-3 cells 
Chen et al. (2011) 
Sensitization of HT-29 cells to TRAIL-induced apoptosis Chen et al. (2011) 
Inhibition of tumor growth in MCF-7 and MDA-231 xenografts in nude mice Lepage et al. (2011) 
Inhibition of melanogenesis by activating the PI3K pathway Srinivasan et al. (2009) 
Apoptosis induction and growth inhibition of HCT-116 human colon carcinoma cells Lee et al. (2007) 
Apoptosis induction and downregulation of COX-2 expression and activity in human rheumatoid synovial cells Raju and Bird (2007) 
Inhibition of viability and proliferation of breast cancer cells Liagre et al. (2007) 
Osteoclastogenesis suppression by inhibiting NF-kappaB-regulated gene expression Li et al. (2005) 
Growth inhibition and apoptosis induction in HT-29 human colon cancer cells Shishodia and Aggarwal (2006) 
p53 activation and cell cycle arrest in the different cell lines Raju et al. (2004) 
Anticancer activity on S-180, HepA, U14 transplant mice and L929, HeLa, MCF cells Corbiere et al. (2004) 
Normalization of lipid levels by excretion through faeces in diabetic rats Wang et al. (2002) 
 
 
progesterone from diosgenin at Parke-Davis Pharmaceutical 
Company, in 1940. Progesterone is produced in various 
formulations by many pharmaceutical companies for 
hormone replacement therapy during menopause. 
Noteworthy, in US, the overall market for this therapy is 
above $3.7 billion. Medicinal uses of diosgenin are 
summarized in Table 4. 
 
Diosgenin extraction methods 
Different methods have been reported for the extraction 
Fig. 2. Chemical structure of Diosgenin (3β,25R)-spirost-5-en-
3-ol) [C27H42O3, 414.621 g mol-1] 
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of crude saponins and pure diosgenin from fenugreek 
tissues. Separation and extraction of diosgenin can be 
carried out by thin-layer chromatography (TLC) or high-
performance thin-layer chromatography (HPTLC), 
whereas, in other methods, it can be extracted directly in 
pure form. In the method described by Li et al. (2012), 
diosgenin was extracted from cultured cells of Dioscorea 
zingiberensis. Cells were ground to a fine powder which was 
immersed in 95% ethanol, subjected to sonication, for 2 h, 
followed by hydrolysis at 121 °C, for 2 h, with 1 mol/L 
sulfuric acid. Then, the hydrolysate was extracted thrice 
with petroleum ether followed by washing with 1 mol/L 
NaOH and distilled water until it became colorless. The 
petroleum ether fraction was concentrated to dryness and, 
finally, dissolved in acetonitrile followed by filtration using 
0.22 μm filter for HPLC analysis (Li et al., 2012). In the 
diosgenin extraction method by Trivedi et al. (2007) 
powder from fenugreek stem, leaf and seed tissues was 
refluxed with 2.5 M ethanolic sulfuric acid at 80 °C, for 4 h, 
cooled and filtered through Whatman filter No. 1. The 
filtrate was diluted with water and extracted with 
chloroform which was, then, evaporated on water bath and 
further eluted in chloroform, before separating on TLC 
plates (Trivedi et al., 2007). In this method, n-hexane can 
also be used instead of chloroform to extract diosgenin, 
which can be dried and dissolved in acetonitrile followed by 
filtration through 0.22 μm filter. This method yields pure 
diosgenin without extraction through TLC or other 
methods. 
 
Diosgenin determination and measurement 
Some methods for determination of diosgenin extracted 
from various plant tissues have been developed, including 
spectrophotometry, TLC, HPTLC, high-performance 
liquid chromatography (HPLC) and gas chromatography 
(GC). In the spectrophotometric method described by 
Baccou et al. (1977) and Uematsu et al. (2000) and 
modified by Chapagain and Wiesman (2005), plant extracts 
were treated with anisaldehyde, sulfuric acid and ethyl 
acetate to be measured at 430 nm for diosgenin 
determination. Trivedi et al. (2007) used calibration curve 
method for quantifying the extracted diosgenin: they found 
the green color spot on the TLC plate corresponding to 
diosgenin at Rf = 0.30 ± 0.04 and visualized the same in 
scanner III at 428nm (Trivedi et al., 2007). Li et al. (2012) 
developed a spectrophotometric method to quantify 
diosgenin. They dissolved the compound in acetonitrile and 
evaporated it till dryness at room temperature followed by 
dissolving diosgenin in perchloric acid and measuring at 410 
nm. They also developed a HPLC method for diosgenin 
analysis and reported a retention time (RT) = 18.064 ± 
0.096 for this compound. 
 
Conclusions 
Fenugreek is a medicinal plant used, since centuries, as 
herbal remedy in many traditional healing systems. This 
plant also represents a significant source of diosgenin, a 
saponin used as precursor for the synthesis of steroid 
hormones. Preclinical studies investigated the 
pharmacological activities of fenugreek and its main 
metabolite diosgenin, focusing on their anti-diabetes, 
cardioprotective, anticancer and antimicrobial properties. 
Noteworthy, fenugreek can be a more suitable alternative 
for diosgenin production than the conventional method 
using yams, due to ease of production, short life cycle and 
less cost. However, the main limitation is the natural 
occurrence of diosgenin present in fenugreek, which is 
around 0.2-0.9%. Therefore, this plant can be targeted to 
increase the yield both in terms of biomass and secondary 
metabolite production by different strategies, including 
genetic engineering, classic breeding, cultivation techniques 
and agricultural practices such as the use of fertilizers (Basu 
et al., 2009; Ahmed et al., 2010). Intriguingly, the use of 
elicitors, such as methyl jasmonate, was shown to 
significantly increase the yield of diosgenin from fenugreek 
plants, upregulating genes involved in its biosynthetic 
pathway (Chaudhary et al., 2015). 
In conclusion, despite the topics focused in this review 
article, various issues related to fenugreek biology, 
phytochemistry and pharmacology still remain to be 
investigated, as well as the therapeutic properties of 
diosgenin need to be substantiated by randomized clinical 
trials. In the future, all these aspects could further improve 
the economic, industrial and medical relevance of these 
natural resources. 
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